INTERNATIONAL PATENT: IMMUNITYBIO, INC. FILES APPLICATION FOR "INTERLEUKIN-15 SUPERAGONIST N-803 IN PEOPLE EXPERIENCING LONG COVID"

GENEVA, Oct. 20 -- IMMUNITYBIO, INC. (9920 Jefferson Blvd.Culver City, California 90232) filed a patent application (PCT/US2025/023642) for "INTERLEUKIN-15 SUPERAGONIST N-803 IN PEOPLE EXPERIENCING LONG COVID" on Apr 08, 2025. With publication no. WO/2025/217157, the details related to the patent application was published on Oct 16, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SOON-SHIONG, Patrick (c/o ImmunityBio, Inc.9920 Jefferson Blvd.Culver City, California 90232), SAFRIT, Jeffrey T. (c/o ImmunityBio, Inc.9920 Jefferson Blvd.Culver City, California 90232)

Abstract: Disclosed herein ...